FDA Guideline: Common Pitfalls, Deviations & Failures During Scale-Up
Developing playbooks for rapid response to scale up failures in commercial supply
Developing Playbooks for Rapid Response to Scale Up Failures in Commercial Supply Developing Playbooks for Rapid Response to Scale Up Failures in Commercial Supply In the pharmaceutical industry, the transition from research and development to commercial supply presents numerous challenges, particularly when it comes to scale-up processes. Regulatory compliance, efficiency, and product quality are paramount, given the scrutiny from authorities such as the FDA, EMA, and MHRA. The importance of robust process validation strategies cannot be overstated, as they form the basis for ensuring successful technology transfer and manufacturing scale-up. Understanding Process Validation: General Principles and Practices Process validation is…
Training teams on known scale dependent failure modes and warning signs
Training Teams on Known Scale Dependent Failure Modes and Warning Signs Training Teams on Known Scale Dependent Failure Modes and Warning Signs The process of scaling up manufacturing operations for pharmaceutical products is often fraught with challenges. Adherence to FDA process validation guidance principles is critical for ensuring that products are consistently produced and controlled according to quality standards. This article will explore the common pitfalls associated with scale-up activities, providing insights on known scale-dependent failure modes and warning signs that can indicate underlying issues. Here, we will also look at the roles of engineering and risk management practices to…